People experiencing incarceration (PEI) have poorer COVID-19 clinical outcomes compared with the general population. Many interventions were implemented in incarceration facilities to mitigate the burden of COVID-19. This systematic review seeks to analyze the effectiveness of these interventions. Twenty-two studies were included. Reduction of the incarcerated population/interfacility transfers, cohorting of new and infectious incarcerated people, mass asymptomatic testing (despite often low uptake), hygiene measures, and prioritization of PEI in vaccine policy had some evidence of effectiveness at reducing transmission and risk of COVID-19 in incarceration facilities. Visitation suspension had conflicting evidence of effectiveness. Studies were of low or medium quality. Inadequate control of confounding variables limited the reliability and validity of conclusions drawn. Many studies relied on retrospective, third-party data. Higher quality research is required.
Get full access to this article
View all access options for this article.
References
1.
AdamsonJ. P., SmithC., PacchiariniN., ConnorT. R., WallsgroveJ., ColesI., FrostC., EdwardsA., SinhaJ., MooreC., PerrettS., CraddockC., SawyerC., WaldramA., BarrasaA., ThomasD. R., DanielsP., & LewisH. (2022). A large outbreak of COVID-19 in a UK prison, October 2020 to April 2021. Epidemiology and Infection, 150, 569–570. https://doi.org/10.1017/S0950268822000991
2.
AkersJ., Aguiar-IbáñezR., & Baba-AkbariA. (2009). Systematic reviews: CRD's guidance for undertaking reviews in health care. Centre for Reviews and Dissemination, University of York.
3.
AyoubkhaniD., BerminghamC., PouwelsK. B., GlickmanM., NafilyanV., ZaccardiF., KhuntiK., AlwanN. A., & WalkerA. S. (2022). Trajectory of long Covid symptoms after Covid-19 vaccination: Community based cohort study. BMJ,, 377, e069676. https://doi.org/10.1136/bmj-2021-069676
4.
BarskyB. A., ReinhartE., FarmerP., & KeshavjeeS. (2021). Vaccination plus decarceration—Stopping Covid-19 in jails and prisons. New England Journal of Medicine, 384(17), 1583–1585. https://doi.org/10.1056/nejmp2100609
5.
BiondiB. E., LeifheitK. M., MitchellC. R., SkinnerA., Brinkley-RubinsteinL., & RaifmanJ. (2022). Association of state COVID-19 vaccination prioritization with vaccination rates among incarcerated persons. JAMA Network Open,, 5(4), E226960. https://doi.org/10.1001/jamanetworkopen.2022.6960
6.
BlackmoreC., CzachorowskiM., FarringtonE., O'Moore, É., & PluggeE. (2022). Testing for COVID-19 during an outbreak within a large UK prison: An evaluation of mass testing to inform outbreak control. International Journal of Infectious Diseases, 125, 138–144. https://doi.org/10.1016/j.ijid.2022.10.018
7.
BlairA., ParniaA., & SiddiqiA. (2021). A time-series analysis of testing and COVID-19 outbreaks in Canadian federal prisons to inform prevention and surveillance efforts. Canada Communicable Disease Report, 47(1), 66–76. https://doi.org/10.14745/ccdr.v47i01a10
8.
BorgesL. P., MartinsA. F., de SouzaD. R. V., de Rezende NetoJ. M., SantosA. A., OliveiraB. M., MatosI. L. S., da InvençãoG. B., Dos SantosK. A., SouzaN. A. A., de JesusP. C., Dos SantosC. A., de Oliveira GoesM. A., de SouzaM. S. F., de Carvalho BarretoI. D., GuimarãesA. G., & Quintans-JúniorL. J. (2021). Does in-person visiting affect the number of COVID-19 cases in prisons?. Life, 11(11), 1184. https://doi.org/10.3390/life11111184
9.
BraithwaiteI., EdgeC., & LewerD. (2021). Indirect age- and sex-standardisation of COVID-19-related mortality rates for the prison population of England and Wales. UCL Collaborative Centre for Inclusion Health. https://doi.org/10.14324/000.rp.10123265
BraunV., & ClarkeV. (2012). Thematic analysis. In APA handbook of research methods in psychology, Vol 2: Research designs: Quantitative, qualitative, neuropsychological, and biological (pp. 57–71). American Psychological Association. https://doi.org/10.1037/13620-004
Brinkley-RubinsteinL., LeMastersK., NguyenP., NowotnyK., CloudD., & VolfovskyA. (2021a). The association between intersystem prison transfers and COVID-19 incidence in a state prison system. PLoS ONE, 16(8), e0256185. https://doi.org/10.1371/journal.pone.0256185
14.
Brinkley-RubinsteinL., PetersonM., MartinR., ChanP., & BerkJ. (2021b). Breakthrough SARS-CoV-2 infections in prison after vaccination. New England Journal of Medicine, 385(11), 1051–1052. https://doi.org/10.1056/NEJMc2108479
ChanJ., BurkeK., BedardR., GriggJ., WintersJ., VessellC., RosnerZ., ChengJ., KatyalM., YangP., & MacdonaldR. (2021). COVID-19 in the New York City jail system: Epidemiology and health care response, March–April 2020. Public Health Reports, 136(3), 375–383. https://doi.org/10.1177/0033354921999385
17.
ChinE. T., LeidnerD., LamsonL., LucasK., StuddertD. M., Goldhaber-FiebertJ. D., AndrewsJ. R., & SalomonJ. A. (2022a). Protection against Omicron from vaccination and previous infection in a prison system. New England Journal of Medicine, 387(19), 1770–1782. https://doi.org/10.1056/NEJMoa2207082
18.
ChinE. T., LeidnerD., ZhangY., LongE., PrinceL., LiY., AndrewsJ. R., StuddertD. M., Goldhaber-FiebertJ. D., & SalomonJ. A. (2021a). Effectiveness of the mRNA-1273 vaccine during a SARS-CoV-2 Delta outbreak in a prison. New England Journal of Medicine, 385(24), 2300–2301. https://doi.org/10.1056/NEJMc2114089
19.
ChinE. T., LeidnerD., ZhangY., LongE., PrinceL., SchragS. J., VeraniJ. R., WiegandR. E., Alarid-EscuderoF., Goldhaber-FiebertJ. D., StuddertD. M., AndrewsJ. R., & SalomonJ. A. (2022b). Effectiveness of coronavirus disease 2019 (COVID-19) vaccines among incarcerated people in California state prisons: Retrospective cohort study. Clinical Infectious Diseases, 75(1), e838–e845. https://doi.org/10.1093/cid/ciab1032
20.
ChinE. T., RyckmanT., PrinceL., LeidnerD., Alarid-EscuderoF., AndrewsJ. R., SalomonJ. A., StuddertD. M., & Goldhaber-FiebertJ. D. (2021b). COVID-19 in the California state prison system: An observational study of decarceration, ongoing risks, and risk factors. Journal of General Internal Medicine, 36(10), 3096–3102. https://doi.org/10.1007/s11606-021-07022-x
21.
ClarkeM., DevlinJ., ConroyE., KellyE., & Sturup-ToftS. (2020). Establishing prison-led contact tracing to prevent outbreaks of COVID-19 in prisons in Ireland. Journal of Public Health, 42(3), 519. https://doi.org/10.1093/PUBMED/FDAA092
22.
ColemanP. C., PailingA., RoyA., O'Moore, É., ChandanJ. S., LumbyV., NewtonP., TaylorA., RobinsonE., SwindellsJ., DowleS., & GajrajR. (2022). Implementation of novel and conventional outbreak control measures in managing COVID-19 outbreaks in a large UK prison. BMC Public Health, 22(1), 677. https://doi.org/10.1186/s12889-022-12991-7
DuarteC., CameronD. B., KwanA. T., BertozziS. M., WilliamsB. A., & McCoyS. I. (2022). COVID-19 outbreak in a state prison: A case study on the implementation of key public health recommendations for containment and prevention. BMC Public Health, 22(1), 1–12. https://doi.org/10.1186/S12889-022-12997-1/FIGURES/2
25.
EdgeC., HardJ., WainwrightL., GipsonD., WainwrightV., ShawJ., DaviesM., AbbottL., BennallickM., & SirdifieldC. (2021). COVID-19 and the prison population: Working paper for the COVID-19 impact inquiry. Health Foundation.
EspositoM., SalernoM., Di NunnoN., MinisteriF., LibertoA., & SessaF. (2022). The risk of COVID-19 infection in prisons and prevention strategies: A systematic review and a new strategic protocol of prevention. Healthcare, 10(2), 270. https://doi.org/10.3390/healthcare10020270
GerleeP., JöudA., SprecoA., & TimpkaT. (2022). Computational models predicting the early development of the COVID-19 pandemic in Sweden: Systematic review, data synthesis, and secondary validation of accuracy. Scientific Reports, 12(1), 13256. https://doi.org/10.1038/s41598-022-16159-6
30.
GnanviJ. E., SalakoK. V., KotanmiG. B., & Glèlè KakaïR. (2021). On the reliability of predictions on Covid-19 dynamics: A systematic and critical review of modelling techniques. Infectious Disease Modelling, 6,258–272. https://doi.org/10.1016/j.idm.2020.12.008
31.
Gouvea-ReisF. A., OliveiraP. D., SilvaD. C. S., BorjaL. S., PercioJ., SouzaF. S., PeterkaC., FeresC., de OliveiraJ., SodréG., dos SantosW., & de MoraesC. (2021). COVID-19 outbreak in a large penitentiary complex, April–June 2020, Brazil. Emerging Infectious Diseases, 27(3), 924–927. https://doi.org/10.3201/eid2703.204079
32.
HaganL. M., WilliamsS. P., SpauldingA. C., ToblinR. L., FiglenskiJ., OcampoJ., RossT., BauerH., HutchinsonJ., LucasK. D., ZahnM., ChiangC., CollinsT., BurakoffA., BettridgeJ., StringerG., MaulR., WatersK., DewartC., … HandanagicS. (2020). Mass testing for SARS-CoV-2 in 16 prisons and jails—six jurisdictions, United States, April-May 2020. Morbidity and Mortality Weekly Report, 69(33), 1139–1143. https://doi.org/https://dx.doi.org/10.15585/mmwr.mm6933a3
33.
HewsonT., ShepherdA., HardJ., & ShawJ. (2020). Effects of the COVID-19 pandemic on the mental health of prisoners. The Lancet Psychiatry, 7(7), 568–570. https://doi.org/10.1016/S2215-0366(20)30241-8
34.
JiménezM. C., CowgerT. L., SimonL. E., BehnM., CassarinoN., & BassettM. T. (2020). Epidemiology of COVID-19 among incarcerated individuals and staff in Massachusetts jails and prisons. JAMA Network Open, 3(8), e2018851. https://doi.org/10.1001/jamanetworkopen.2020.18851
35.
KimH., HughesE., CavanaghA., NorrisE., GaoA., BondyS. J., McLeodK. E., KanagalingamT., & KouyoumdjianF. G. (2022). The health impacts of the COVID-19 pandemic on adults who experience imprisonment globally: A mixed methods systematic review. PLoS One, 17(5), e0268866. https://doi.org/10.1371/journal.pone.0268866
36.
KwanA., SklarR., CameronD. B., SchellR. C., BertozziS. M., McCoyS. I., WilliamsB., & SearsD. A. (2023). Respiratory pandemic preparedness learnings from the June 2020 COVID-19 outbreak at San Quentin California state prison. International Journal of Prisoner Health, 19(3), 306–321. https://doi.org/10.1108/IJPH-12-2021-0116/FULL/PDF
37.
LeibowitzA. I., SiednerM. J., TsaiA. C., & MoharebA. M. (2021). Association between prison crowding and COVID-19 incidence rates in Massachusetts prisons, April 2020–January 2021. JAMA Internal Medicine, 181(10), 1315. https://doi.org/10.1001/jamainternmed.2021.4392
38.
LemastersK., McCauleyE., NowotnyK., & Brinkley-RubinsteinL. (2020). COVID-19 cases and testing in 53 prison systems. Health & Justice, 8(1), 24. https://doi.org/10.1186/s40352-020-00125-3
39.
LiuY. E., OtoJ., WillJ., LeBoaC., DoyleA., RensN., AggarwalS., KalishI., RodriguezM., SherifB., TrinidadC., Del RosarioM., AllenS., SpencerR., MoralesC., ChyornyA., & AndrewsJ. R. (2022). Factors associated with COVID-19 vaccine acceptance and hesitancy among residents of Northern California jails. Preventive Medicine Reports, 27, 101771. https://doi.org/10.1016/j.pmedr.2022.101771
40.
MarcoA., GallegoC., Pérez-CáceresV., GuerreroR. A., Sánchez-RoigM., Sala-FarréR. M., Fernández-NágerJ., & TuruE. (2021). Public health response to an outbreak of SARS-CoV2 infection in a Barcelona prison. Epidemiology and Infection, 149, e91. https://doi.org/10.1017/S0950268821000789
41.
MarcoA., SoléC., AbdoI. J., & TuruE. (2022). Low sensitivity of rapid antigenic tests as a screening method in an outbreak of SARS-CoV-2 infection in prison (Baja sensibilidad de los test rápidos antigénicos como método decribado en un brote de infección por SARS-CoV-2 en prisión). Enfermedades Infecciosas y Microbiologia Clinica, 40(3), 152–154. https://doi.org/10.1016/j.eimc.2021.01.010
42.
MarmolejoL., BarberiD., BergmanM., EspinozaO., & FondevilaG. (2020). Responding to COVID-19 in Latin American prisons: The cases of Argentina, Chile, Colombia, and Mexico. Victims & Offenders, 15(7–8), 1062–1085. https://doi.org/10.1080/15564886.2020.1827110
43.
MarquezN. M., LittmanA., RossiV., EverettM., TyagiE., JohnsonH., & DolovichS. (2021). Assessing the mortality impact of the COVID-19 pandemic in Florida state prisons. MedRxiv: The Preprint Server for Health Sciences. https://doi.org/10.1101/2021.04.14.21255512
44.
MazzilliS., OlianiF., RestivoA., GiulianiR., TavoschiL., & RanieriR. (2021). Antigenic rapid test for SARS-CoV2 screening of individuals newly admitted to detention facilities: Sensibility in an asymptomatic cohort. Journal of Clinical Virology Plus, 1(1–2), 100019. https://doi.org/10.1016/j.jcvp.2021.100019
45.
MazzilliS., TavoschiL., SoriaA., ForniliM., CoccaG., SebastianiT., ScardinaG., CaironeC., ArzilliG., LapadulaG., CeccarelliL., CoccoN., BartolottiR., De VecchiS., PlacidiG., RezzonicoL., BagliettoL., GiulianiR., & RanieriR. (2022). COVID-19 infection among incarcerated individuals and prison staff in Lombardy, Italy, March 2020 to February 2021. JAMA Network Open, 5(3), e224862. https://doi.org/10.1001/jamanetworkopen.2022.4862
46.
McCarthyC. V., O'MaraO., van LeeuwenE., SherrattK., AbbasK., WongK. L., AtkinsK. E., LoweR., MeakinS. R., DaviesN. G., RussellT. W., O'ReillyK., HuéS., FinchE., Villabona-ArenasC. J., EdmundsW. J., JafariY., TullyD. C., BosseN. I., … SandmannF. (2022). The impact of COVID-19 vaccination in prisons in England and Wales: A metapopulation model. BMC Public Health, 22(1), 1003. https://doi.org/10.1186/s12889-022-13219-4
47.
MigishaR., MorukilengJ., BiribawaC., KadoberaD., KisambuJ., BulageL., NdyabakiraA., KatanaE., MillsL. A., ArioA. R., & HarrisJ. R. (2022). Investigation of a COVID-19 outbreak at a regional prison, Northern Uganda, September 2020. Pan African Medical Journal, 43, 10. https://doi.org/10.11604/pamj.2022.43.10.33598
48.
MoolaS., MunnZ., TufanaruC., AromatarisE., SearsK., SfetcuR., CurrieM., QureshiR., MattisP., LisyK., & MuP.-F. (2020). Chapter 7: Systematic reviews of etiology and risk. In E. Aromataris & Z. Munn (Eds.), JBI manual for evidence synthesis. JBI. https://synthesismanual.jbi.global
49.
MunnZ., MoolaS., LisyK., RItanoD., & TufanaruC. (2015). Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and incidence data. International Journal of Evidence-Based Healthcare, 13(3), 147–153. https://doi.org/10.1097/XEB.0000000000000054
NixonK., JindalS., ParkerF., ReichN. G., GhobadiK., LeeE. C., TrueloveS., & GardnerL. (2022). An evaluation of prospective COVID-19 modelling studies in the USA: From data to science translation. The Lancet Digital Health, 4(10),e738–e747. https://doi.org/10.1016/S2589-7500(22)00148-0
53.
NoviskyM. A., NowotnyK. M., JacksonD. B., TestaA., & VaughnM. G. (2021). Incarceration as a fundamental social cause of health inequalities: Jails, prisons and vulnerability to COVID-19. British Journal of Criminology, 61(6),1630–1646. Oxford University Press. https://doi.org/10.1093/bjc/azab023
54.
PaganoA. M., MaieseA., IzzoC., MaieseA., AmetranoM., De MatteisA., AttianeseM. R., BusatoG., CarusoR., CestariM., De BiasiS., De ChiaraA., De MatteisG., GoffrediG., & La RussaR. (2020). COVID-19 risk management and screening in the penitentiary facilities of the Salerno Province in Southern Italy. International Journal of Environmental Research and Public Health, 17(21), 8033. https://doi.org/10.3390/ijerph17218033
55.
PageM. J., McKenzieJ. E., BossuytP. M., BoutronI., HoffmannT. C., MulrowC. D., ShamseerL., TetzlaffJ. M., AklE. A., BrennanS. E., ChouR., GlanvilleJ., GrimshawJ. M., HróbjartssonA., LaluM. M., LiT., LoderE. W., Mayo-WilsonE., McDonaldS., … MoherD. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, 372, n71. https://doi.org/10.1136/bmj.n71
56.
ParodiC., OttavianoE., CoccoN., AnconaS., BianchiS., MassaV., BartolottiR., PezzoniB., GiulianiR., BorghiE., & RanieriR. (2022). Feasibility and acceptability of saliva-based testing for the screening of SARS-CoV-2 infection in prison. Frontiers in Public Health, 10, 808030. https://doi.org/10.3389/fpubh.2022.808030
57.
ParsonsT. L., & WordenL. (2021). Assessing the risk of cascading COVID-19 outbreaks from prison-to-prison transfers. Epidemics, 37, 100532. https://doi.org/10.1016/j.epidem.2021.100532
58.
PittsW. J., & InkpenC. S. (2020). Assessing the effects of COVID-19 in prisons in the Northern Triangle of Central America. Victims & Offenders, 15(7–8),1044–1061. https://doi.org/10.1080/15564886.2020.1828211
RapisardaS. S., & ByrneJ. M. (2020). An examination of COVID-19 outbreaks in prisons and jails in Oceania. Victims & Offenders, 15(7–8),1361–1366. https://doi.org/http://dx.doi.org/10.1080/15564886.2020.1835767
62.
RapisardaS. S., ByrneJ., & MarmolejoL. (2020). An examination of COVID-19 outbreaks in prisons and jails in North America, Central America, and the Caribbean. Victims & Offenders, 15(7–8),1234–1243. https://doi.org/http://dx.doi.org/10.1080/15564886.2020.1835766
63.
ReinhartE., & ChenD. L. (2021). Association of jail decarceration and anticontagion policies with COVID-19 case growth rates in US counties. JAMA Network Open, 4(9), e2123405. https://doi.org/10.1001/jamanetworkopen.2021.23405
SalvatoreP. P., LeeC. C., SleweonS., McCormickD. W., NicolaeL., KnipeK., DixonT., BantaR., OgleI., YoungC., DusseauC., SalmonsonS., OgdenC., GodwinE., BallomT., RhodesT., WynnN. T., DavidE., BesseyT. K., … HaganL. M. (2023). Transmission potential of vaccinated and unvaccinated persons infected with the SARS-CoV-2 Delta variant in a federal prison, July–August 2021. Vaccine, 41(11), 1808–1818. https://doi.org/10.1016/j.vaccine.2022.11.045
66.
SilvermanR. A., CeciA., CohenA., HelmickM., ShortE., BordwineP., FriedlanderM. J., & FinkielsteinC. V. (2022). Vaccine effectiveness during outbreak of COVID-19 Alpha (B.1.1.7) variant in men's correctional facility, United States. Emerging Infectious Diseases, 28(7), 1313–1320. https://doi.org/10.3201/eid2807.220091
67.
SimwanzaJ., HinesJ. Z., SinyangeD., SinyangeN., MulengaC., HanyinzaS., SakubitaP., LangaN., NowaH., GardnerP., SaasaN., ChitempaG., SimpungweJ., MalamboW., HamainzaB., ChipimoP. J., KapataN., KapinaM., MusondaK., … ChilengiR. (2022). COVID-19 vaccine effectiveness during a prison outbreak when Omicron was the dominant circulating variant—Zambia, December 2021. American Journal of Tropical Medicine and Hygiene, 107(5), 1055–1059. https://doi.org/10.4269/ajtmh.22-0368
68.
StrodelR., DaytonL., Garrison-DesanyH. M., EberG., BeyrerC., ArscottJ., RubensteinL., & SufrinC. (2021). COVID-19 vaccine prioritization of incarcerated people relative to other vulnerable groups: An analysis of state plans. PLoS ONE, 16(6), e0253208. https://doi.org/10.1371/journal.pone.0253208
69.
StufanoA., BuonvinoN., CagnazzoF., ArmeniseN., PontrelliD., CurzioG., De BenedictisL., & LovreglioP. (2021). Efficacy of the measures adopted to prevent COVID-19 outbreaks in an Italian correctional facility for inmates affected by chronic diseases. Frontiers in Public Health, 9, 694795. https://doi.org/10.3389/fpubh.2021.694795
70.
StufanoA., BuonvinoN., TrombettaC. M., PontrelliD., MarchiS., LobefaroG., De BenedictisL., LorussoE., CarofiglioM. T., VasiniotiV. I., MontomoliE., DecaroN., & LovreglioP. (2022). COVID-19 outbreak and BNT162b2 mRNA vaccination coverage in a correctional facility during circulation of the SARS-CoV-2 Omicron BA.1 variant in Italy. Vaccines, 10(7), 1137. https://doi.org/10.3390/vaccines10071137
71.
The EndNote Team. (2013). Endnote (EndNote 20). Clarivate.
72.
ToblinR. L., & HaganL. M. (2021). COVID-19 case and mortality rates in the Federal Bureau of Prisons. American Journal of Preventive Medicine, 61(1), 120. https://doi.org/http://dx.doi.org/10.1016/j.amepre.2021.01.019
73.
TowersS., WallaceD., WalkerJ., EasonJ., NelsonJ., & GrubesicT. (2021). A study of SARS-COV-2 outbreaks in US federal prisons: The linkage between staff, inmate, and community transmission. ResearchSquare. https://doi.org/10.21203/rs.3.rs-384292/v1
VestN., JohnsonO., NowotnyK., & Brinkley-RubinsteinL. (2021). Prison population reductions and COVID-19: A latent profile analysis synthesizing recent evidence from the Texas state prison system. Journal of Urban Health, 98(1), 53–58. https://doi.org/10.1007/s11524-020-00504-z
76.
WadhwaA., FisherK. A., SilverR., KohM., AronsM. M., MillerD. A., McIntyreA. F., VuongJ. T., KimK., TakamiyaM., BinderA. M., TateJ. E., ArmstrongP. A., BlackS. R., MennellaC. C., LevinR., GubserJ., JonesB., WelbelS. F., … ZawitzC. J. (2021). Identification of presymptomatic and asymptomatic cases using cohort-based testing approaches at a large correctional facility—Chicago, Illinois, USA, May 2020. Clinical Infectious Diseases, 72(5),E128–E135. https://doi.org/10.1093/cid/ciaa1802
77.
WilburnJ., BlakeyE., TrindallA., BurrH., TantiV., DoolanS., PalmerI., JewellT., & BalakrishnanR. (2021). COVID-19 within a large UK prison with a high number of vulnerable adults, March to June 2020: An outbreak investigation and screening event. International Journal of Infectious Diseases, 104,349–353. https://doi.org/10.1016/j.ijid.2021.01.027
78.
World Health Organization. (2020). Preparedness, prevention and control of COVID-19 in prisons and other places of detention, Interim guidance. https://doi.org/10665/341332
79.
ZawitzC., WelbelS., GhinaiI., MennellaC., LevinR., SamalaU., SmithM. B., GubserJ., JonesB., VarelaK., KirbiyikU., RafinskiJ., FitzgeraldA., OrrisP., BahlsA., BlackS. R., BinderA. M., & ArmstrongP. A. (2021). Outbreak of COVID-19 and interventions in a large jail—Cook County, IL, United States, 2020. American Journal of Infection Control, 49(9), 1129–1135. https://doi.org/10.1016/j.ajic.2021.03.020
80.
ZevelevaO., & Nazif-MunozJ. I. (2022). COVID-19 and European carcerality: Do national prison policies converge when faced with a pandemic?. Punishment & Society, 24(4), 642–666. https://doi.org/10.1177/14624745211002011
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
